Document type
ArticleVersion
Published versionPublication date
All rights reserved
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/178505
Diagnosis and management of the antiphospholipid syndrome
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
The antiphospholipid syndrome is a systemic autoimmune disease defined by thrombotic or obstetrical events that occur in patients with persistent antiphospholipid antibodies. Thrombotic antiphospholipid syndrome is characterized by venous, arterial, or microvascular thrombosis. Patients with catastrophic antiphospholipid syndrome present with thrombosis involving multiple organs. Obstetrical antiphospholipid syndrome is characterized by fetal loss after the 10th week of gestation, recurrent early miscarriages, intrauterine growth restriction, or severe preeclampsia.1 The major nonthrombotic manifestations of antiphospholipid-antibody positivity include valvular heart disease, livedo, antiphospholipidantibody-related nephropathy, thrombocytopenia, hemolytic anemia, and cognitive dysfunction. The antiphospholipid syndrome is often associated with other systemic autoimmune diseases such as systemic lupus erythematosus (SLE); however, it commonly occurs without other autoimmune manifestations (primary antiphospholipid syndrome).
Subject
Subject (English)
Citation
Citation
RIERA MESTRE, Antoni and VIDALLER PALACÍN, Antonio. Diagnosis and management of the antiphospholipid syndrome. New England Journal of Medicine. 2018. Vol. 379, num. 13, pags. 1289-1290. ISSN 0028-4793. [consulted: 16 of August of 2026]. Available at: https://hdl.handle.net/2445/178505